Novo Integrated Sciences Price to Free Cash Flow Ratio 2012-2024 | NVOS

Novo Integrated Sciences price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as

Novo Integrated Sciences Price to Free Cash Flow Ratio 2012-2024 | NVOS

Novo Integrated Sciences price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.4B
Quest Diagnostics (DGX)$18.2B
DaVita (DVA)$14.4B
Encompass Health (EHC)$10B
Chemed (CHE)$8.5B
Elanco Animal Health (ELAN)$5.9B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$4.8B
LifeStance Health (LFST)$3B
Amedisys (AMED)$3B
Addus HomeCare (ADUS)$2.3B
Astrana Health (ASTH)$2.1B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$909M
Aveanna Healthcare Holdings (AVAH)$889M
Atai Life Sciences (ATAI)$260M
Bioqual (BIOQ)$55M
Daxor (DXR)$37M
Ontrak (OTRK)$7M
MEDIROM Healthcare Technologies (MRM)$5M
IMAC Holdings (BACK)$1M
Psychemedics (PMD)$0M